申请人:Hoffmann-La Roche Inc.
公开号:US20140303149A1
公开(公告)日:2014-10-09
Compounds of the formula I or II:
wherein X, m, Ar, R
1
and R
2
are as defined herein. The subject compounds are useful for treatment of IRAK-mediated conditions.
公式I或II的化合物:其中X,m,Ar,R1和R2的定义如本文所述。该化合物可用于治疗IRAK介导的疾病。